[Federal Register Volume 82, Number 189 (Monday, October 2, 2017)]
[Notices]
[Page 45867]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20990]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Muscular Dystrophy 
Coordinating Committee.
    The meeting will be open to the public and accessible by 
teleconference and live WebEx. Members of the public who wish to 
participate using WebEx should contact the Contact Person listed on 
this notice for the WebEx details. Individuals who plan to participate 
and need special assistance, such as reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Type of meeting: Open Meeting.
    Date: December 5, 2017.
    Time: 1:00 p.m. to 2:30 p.m. *Eastern Time*
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups, other voluntary health organizations, and patients 
and families to update one another on progress relevant to the 
Action Plan for the Muscular Dystrophies.
    Place: National Institutes of Health, 6001 Executive Boulevard, 
Rockville, MD 20852 (Telephone Conference Call).
    Call-In Number: 1-650-479-3208.
    Public Access Code: 622 734 375.
    Contact Person: Glen Nuckolls, Ph.D., Program Director, National 
Institute of Neurological Disorders and Stroke, NIH, 6001 Executive 
Boulevard, Room 2203, Rockville, MD 20892, Phone: (301) 496-5876, 
Email: [email protected].

    Prior to the meeting, an agenda will be posted to the MDCC Web 
site: www.mdcc.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: September 26, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-20990 Filed 9-29-17; 8:45 am]
 BILLING CODE 4140-01-P